Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. SunRock, Escugen Partner To Develo
Thirteen medicines were backed for pan-EU marketing authorizations this week by the European Medicines Agency’s human medicines committee, the CHMP, including Madrigal Pharmaceuticals’ Rezdiffra (resm
Teva and China’s Shanghai Fosun Pharmaceutical have welcomed a significant step forward in the global development of Teva’s novel immunocytokine fusion protein candidate TEV-56278, striking a strategi
The Tariffs Before Tariffs In the years after the pandemic, but before the US-initiated trade wars hung over markets, the term ‘drug tariffs’ had a different significance. In Europe, especially Franc